|
Beta Glucan -The
risk of infectious disease is growing with the rise in
antibiotic-resistant infections, emerging infections, and bioterrorism.
Numerous preclinical and clinical studies support the efficacy of yeast
beta glucans to protect against a wide-variety of gram-positive and
gram-negative bacteria, antibiotic-resistant bacteria, fungal, parasitic
and viral infections. The basis for this anti-infective protective
effect is an enhancement of the innate immune system's ability to kill
these infectious agents, resulting in a 10-20 fold higher infectious
load to cause an infection in a preclinical rat model of infection.
|
